Global Mucopolysaccharidoses (mps) Treatment Market Size & Outlook
Global mucopolysaccharidoses (mps) treatment market, 2015-2027 (US$M)
Related Markets
Global mucopolysaccharidoses (mps) treatment market highlights
- The global mucopolysaccharidoses (mps) treatment market generated a revenue of USD 2,506.8 million in 2020 and is expected to reach USD 4,039.7 million by 2027.
- The market is expected to grow at a CAGR (2021 - 2027) of 7.1% by 2027.
- In terms of segment, ert accounted for a revenue of USD 1,995.2 million in 2020.
- ERT is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- In terms of region, Europe was the largest revenue generating market in 2020.
- Country-wise, U.S. is expected to register the highest CAGR from 2021 to 2027.
Global data book summary
| Market revenue in 2020 | USD 2,506.8 million |
| Market revenue in 2027 | USD 4,039.7 million |
| Growth rate | 7.1% (CAGR from 2020 to 2027) |
| Largest segment | Ert |
| Fastest growing segment | ERT |
| Historical data covered | 2015 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | ERT, HSCT |
Other key industry trends
- In terms of revenue, the North America accounted for 31.6% of the global mucopolysaccharidoses (mps) treatment market in 2020.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2027.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 1,068.7 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mucopolysaccharidoses (MPS) Treatment Market Scope
Mucopolysaccharidoses (MPS) Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global mucopolysaccharidoses (mps) treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mucopolysaccharidoses (mps) treatment market will help companies and investors design strategic landscapes.
Ert was the largest segment with a revenue share of 79.59% in 2020. Horizon Databook has segmented the Global mucopolysaccharidoses (mps) treatment market based on ert, hsct covering the revenue growth of each sub-segment from 2015 to 2027.
- Global Mucopolysaccharidoses (MPS) Treatment Treatment Type Outlook (Revenue, USD Million, 2015-2027)
- ERT
- HSCT
- Global Mucopolysaccharidoses (MPS) Treatment Indication Outlook (Revenue, USD Million, 2015-2027)
- MPS Type I
- MPS Type II
- MPS Type IV
- MPS Type VI
- MPS Type VII
- Others (Type IX & Type III)
Reasons to subscribe to Global mucopolysaccharidoses (mps) treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global mucopolysaccharidoses (mps) treatment market databook
-
Our clientele includes a mix of mucopolysaccharidoses (mps) treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global mucopolysaccharidoses (mps) treatment market, including forecasts for subscribers. This global databook contains high-level insights into Global mucopolysaccharidoses (mps) treatment market from 2015 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Global mucopolysaccharidoses (mps) treatment market size, by regions, 2015-2027 (US$M)
Top 10 countries: Mucopolysaccharidoses (mps) treatment market size, 2020 (US$M)
Global mucopolysaccharidoses (mps) treatment market share, by treatment type, 2020 & 2027 (%, US$M)
Mucopolysaccharidoses (mps) treatment market: Opportunity assessment by country
Global mucopolysaccharidoses (mps) treatment market, by region, 2020 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
